You are here

Regeneron announces more positive results for Covid-19 treatment

rk_Regeneron_291020.jpg
Regeneron, the US biotech firm that supplied synthetic antibodies to treat President Donald Trump's Covid-19, announced on Wednesday it had more positive results to show from an ongoing clinical trial.

[WASHINGTON] Regeneron, the US biotech firm that supplied synthetic antibodies to treat President Donald Trump's Covid-19, announced on Wednesday it had more positive results to show from an ongoing clinical trial.

The company had previously announced results for 275 people in its late-...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes